Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M41,535Revenue $M26,095Net Margin (%)4.9Altman Z-Score2.0
Enterprise Value $M89,200EPS $0.5Operating Margin %8.6Piotroski F-Score3
P/E(ttm)134Beneish M-Score-2.9Pre-tax Margin (%)4.9Higher ROA y-yN
Price/Book4.710-y EBITDA Growth Rate %4.7Quick Ratio0.7Cash flow > EarningsY
Price/Sales6.65-y EBITDA Growth Rate %-16.2Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow65.8y-y EBITDA Growth Rate %-34.4ROA % (ttm)2.2Higher Current Ratio y-yN
Dividend Yield %4.3PEG--ROE % (ttm)6.3Less Shares Outstanding y-yN
Payout Ratio %277Shares Outstanding M1,264ROIC % (ttm)8.1Gross Margin Increase y-yN

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNDavid Dreman 2015-03-31 Reduce-0.01%$64.44 - $72.7
($69.48)
$ 32.86-53%Reduce 4.43%27,489
AZNNWQ Managers 2015-03-31 Reduce-0.01%$64.44 - $72.7
($69.48)
$ 32.86-53%Reduce 21.34%52,265
AZNMario Gabelli 2015-03-31 Reduce$64.44 - $72.7
($69.48)
$ 32.86-53%Reduce 40.70%11,800
AZNDavid Dreman 2014-12-31 Reduce-0.51%$67.15 - $75.38
($71.66)
$ 32.86-54%Reduce 75.42%28,764
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$67.15 - $75.38
($71.66)
$ 32.86-54%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$67.15 - $75.38
($71.62)
$ 32.86-54%Reduce 52.51%19,900
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$68.49 - $76.31
($73.2)
$ 32.86-55%Sold Out0
AZNCharles Brandes 2014-06-30 Reduce-0.78%$62.45 - $81.09
($72.26)
$ 32.86-55%Reduce 71.06%386,058
AZNJoel Greenblatt 2014-06-30 Sold Out -0.09%$62.45 - $81.09
($72.26)
$ 32.86-55%Sold Out0
AZNGeorge Soros 2014-06-30 Buy 0.08%$62.45 - $81.09
($72.26)
$ 32.86-55%New holding150,000
AZNMario Gabelli 2014-06-30 Buy 0.02%$62.45 - $81.09
($72.26)
$ 32.86-55%New holding40,400
AZNNWQ Managers 2014-06-30 Reduce-0.01%$62.45 - $81.09
($72.26)
$ 32.86-55%Reduce 24.55%64,475
AZNHOTCHKIS & WILEY 2014-03-31 Sold Out -0.93%$58.51 - $68.38
($64.41)
$ 32.86-49%Sold Out0
AZNCharles Brandes 2014-03-31 Reduce-0.84%$58.51 - $68.15
($64.29)
$ 32.86-49%Reduce 46.73%1,333,894
AZNDavid Dreman 2014-03-31 Add0.14%$58.51 - $68.38
($64.41)
$ 32.86-49%Add 26.61%135,439
AZNJoel Greenblatt 2014-03-31 Buy 0.09%$58.51 - $68.38
($64.41)
$ 32.86-49%New holding95,518
AZNDavid Dreman 2013-12-31 Reduce-0.34%$49.72 - $59.5
($54.28)
$ 32.86-39%Reduce 40.32%106,975
AZNHOTCHKIS & WILEY 2013-12-31 Reduce-0.3%$49.72 - $59.5
($54.28)
$ 32.86-39%Reduce 24.90%3,689,214
AZNCharles Brandes 2013-09-30 Add0.12%$47.88 - $52.08
($50.24)
$ 32.86-35%Add 7.92%2,381,040
AZNHOTCHKIS & WILEY 2013-06-30 Add0.68%$47.22 - $53.01
($50.92)
$ 32.86-35%Add 131.18%4,944,742
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$1792.41view

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Last Month Insiders Bought Over $300 Million Of This Biotech Jun 26 2015 
    Guru Stocks at 52-Week Lows: XOM, WMT, CVX, AZN, COP Jun 21 2015 
    Amgen And AstraZeneca’s Deal On Psoriasis Drug Faces Termination May 27 2015 
    Johnson & Johnson A Good Investment Despite Current Lows May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
    Regulus Therapeutics (RGLS) microRNA Therapeutic Milestone Payment, Dave & Buster's Entertainment (P Apr 08 2015 
    Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 
    Merck Takes A Step Forward In The World Of Medicine Jan 16 2015 
    Brandes International Equity Fund Q3 Commentary Dec 23 2014 

    More From Other Websites
    AstraZeneca to present data demonstrating progress of its comprehensive diabetes portfolio at the... Jul 28 2015
    Sanofi paying up to $300M for rare thyroid cancer drug Jul 27 2015
    Sanofi paying up to $300M for rare thyroid cancer drug Jul 27 2015
    AZN sells off non-core drugs Jul 27 2015
    Splits Calendar: AstraZeneca splits before market open today (2:1 ratio) Jul 27 2015
    AstraZeneca sells rare cancer drug to Sanofi for up to $300 mln Jul 27 2015
    AstraZeneca sells rare cancer drug to Sanofi for up to $300 mln Jul 27 2015
    European Factors-Futures lower as China woes spread Jul 27 2015
    AstraZeneca sells rare cancer drug to Sanofi for up $300 mln Jul 27 2015
    AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa Jul 27 2015
    Sanofi to Buy Caprelsa Drug from AstraZeneca for $300 Million Jul 27 2015
    AbbVie: Beware the Biosimilars? Jul 24 2015
    AstraZeneca chases biosimilar Avastin drug with Japanese group Jul 24 2015
    Bwin's activist Ader glosses over the ugliness of battle Jul 22 2015
    AstraZeneca suffers setback after drug fails to treat eye cancer Jul 22 2015
    Should You Invest In AstraZeneca plc, Shire PLC And Abcam Plc? Jul 22 2015
    AstraZeneca suffers setback as drug fails in eye cancer Jul 22 2015
    AstraZeneca provides update on selumetinib in uveal melanoma Jul 22 2015
    Pfizer ranked top foreign research partner for UK academics Jul 19 2015
    AstraZeneca Strikes Deal to Market Benralizumab in Japan - Analyst Blog Jul 17 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK